Medical treatment and other combination regimens.
Unità di Oncologia Medica 2, Dipartimento di Oncologia Medica, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano.
Emilio
E
Bajetta
Michele
M
Del Vecchio
Roberto
R
Bajetta
Stefania
S
Canova
D020533:Angiogenesis Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use; D018906:Antineoplastic Agents, Alkylating / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D001932:Brain Neoplasms / Q000188:drug therapy* / Q000556:secondary*; D000068579:Celecoxib; D017322:Clinical Trials, Phase II as Topic; D017326:Clinical Trials, Phase III as Topic; D003131:Combined Modality Therapy; D003606:Dacarbazine / Q000031:analogs & derivatives / Q000627:therapeutic use; D018450:Disease Progression; D019008:Drug Resistance, Neoplasm; D006402:Hematologic Diseases / Q000139:chemically induced; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use; D007167:Immunotherapy; D007372:Interferons / Q000008:administration & dosage / Q000627:therapeutic use; D008545:Melanoma / Q000188:drug therapy* / Q000556:secondary*; D009607:Nitrosourea Compounds / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D009943:Organophosphorus Compounds / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D011720:Pyrazoles / Q000008:administration & dosage / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic; D012878:Skin Neoplasms / Q000188:drug therapy*; D013449:Sulfonamides / Q000008:administration & dosage / Q000627:therapeutic use; D016019:Survival Analysis; D000077204:Temozolomide; D016896:Treatment Outcome
D020533:Angiogenesis Inhibitors; D018906:Antineoplastic Agents, Alkylating; D007155:Immunologic Factors; D009607:Nitrosourea Compounds; D009943:Organophosphorus Compounds; D011720:Pyrazoles; D013449:Sulfonamides; D003606:Dacarbazine; D007372:Interferons; C054368:fotemustine; D000068579:Celecoxib; D000077204:Temozolomide